Exelixis Inc. (EXEL)
NASDAQ · Healthcare
Exelixis Inc. EBITDA 2009–2026
Exelixis Inc. annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Exelixis Inc. ebitda for the quarter ending April 3, 2026 was 258.3 M, a 33.00% increase year-over-year.
- Exelixis Inc. ebitda for the twelve months ending April 3, 2026 was 524.0 M, a 129.98% increase year-over-year.
- Exelixis Inc. annual ebitda for 2026 was 901.2 M, a 42.28% increase from 2025.
- Exelixis Inc. annual ebitda for 2025 was 633.4 M, a 222.18% increase from 2023.
- Exelixis Inc. annual ebitda for 2023 was 196.6 M, a 11.58% decrease from 2022.
- Exelixis Inc. annual ebitda for 2022 was 222.4 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Exelixis Inc. EBITDA — FAQ
Exelixis Inc. (EXEL) ebitda over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EXEL's ebitda history?
The chart and table above show Exelixis Inc.'s ebitda by year and by quarter, including the growth rate.